Differences between social media and regulatory databases in adverse drug reaction discovery

SoMeRA 2014 - Proceedings of the 1st ACM International Workshop on Social Media Retrieval and Analysis, Co-located with SIGIR 2014

Volumn , Issue , 2014, Pages 13-14

  Wang, Chen ^a   Karimi, Sarvnaz ^a  

^a CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH; PHARMACODYNAMICS;

ADVERSE DRUG REACTIONS; CONTEXT INFORMATION; CONTROVERSIAL TOPICS; EXTRACTING INFORMATION; HEALTH ISSUES; PATIENT CONDITION; POLITICAL PARTIES; SOCIAL MEDIA;

SOCIAL NETWORKING (ONLINE);

EID: 84908657792     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1145/2632188.2632201     Document Type: Conference Paper

References (4)

1. P. Coloma, G. Trifiró, V. Patadia, and M. Sturkenboom. Postmarketing safety surveillance. Drug Saf, 36(3):183-197, 2013.
2. B. Hug, C. Keohane, D. Seger, C. Yoon, and D. Bates. The costs of adverse drug events in community hospitals. Jt Comm J Qual Patient Saf, 38(3):120-126, 2012.
3. A. Metke-Jimenez, S. Karimi, and C. Paris. Evaluation of text processing algorithms for adverse drug event extraction from social media. In SoMeRA, Gold Coast, Australia, 2014.
4. E. Roughead and S. Semple. Medication safety in acute care in Australia: Where are we now? part 1: A review of the extent and causes of medication problems 2002-2008. ANZHP, 6(1):18, 2009.